Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
Bo Zhu, Siu‐Lung Chan, Jack Li, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 640-640
Open Access | Times Cited: 41
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
Inês Domingues, Isabelle Leclercq, Ana Beloqui
Journal of Controlled Release (2023) Vol. 363, pp. 415-434
Closed Access | Times Cited: 28
The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence
Lanyi Wei, Wenrui Zhang, Yueyang Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 30
Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 40
Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota
Gege Tian, Wei Wang, Enrui Xia, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 15
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus
Biomedicines (2022) Vol. 11, Iss. 1, pp. 106-106
Open Access | Times Cited: 20
Liver-derived metabolites as signaling molecules in fatty liver disease
Umur Keles, Jin Rong Ow, Katharina B. Kuentzel, et al.
Cellular and Molecular Life Sciences (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 19
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Wesam Bahitham, S. Al-Ghamdi, Ibrahim Omer, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 550-550
Open Access | Times Cited: 4
Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
Zifeng Yang, Ruifeng Tian, Xiao‐Jing Zhang, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 9
Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
Yajie Cai, Qiaoning Yang, Yanqiao Yu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
Hu Li, Nannan Liu, Jianrui Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know
Viktoriya Bikeyeva, Ahmad Makmom Abdullah, Aleksandra Radivojevic, et al.
Cureus (2022)
Open Access | Times Cited: 13
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
Osama A. Mohammed, Mahmoud E. Youssef, Ahmed S. Doghish, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 198, pp. 106792-106792
Open Access | Times Cited: 2
Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Kamlesh K. Bhopale, Mukund P. Srinivasan
Livers (2023) Vol. 3, Iss. 4, pp. 597-617
Open Access | Times Cited: 6
Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis
Bo Zhu, Hao Wu, Kathryn Li, et al.
Vascular Pharmacology (2023) Vol. 154, pp. 107249-107249
Closed Access | Times Cited: 6
The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver Disease
Preethi Chandrasekaran, Ralf Weiskirchen
Livers (2023) Vol. 4, Iss. 1, pp. 1-14
Open Access | Times Cited: 4
Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection
Henry Lik‐Yuen Chan, Yao Hu, Katharina Malinowsky, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Efficacy and safety of resmetirom for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis
Muhammad Talha, Mohammad Haris Ali, Zain Ali Nadeem, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 37, Iss. 3, pp. 247-256
Closed Access | Times Cited: 1
Physical exercise positively modulates nonalcoholic steatohepatitis‐related hepatic endoplasmic reticulum stress
Emanuel Passos, Cidália Pereira, Inês O. Gonçalves, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 10, pp. 1647-1662
Closed Access | Times Cited: 7
Is Fasting Good When One Is at Risk of Liver Cancer?
Iulia Minciună, Laurens A. van Kleef, Horia Ştefănescu, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5084-5084
Open Access | Times Cited: 7
Novel Noninvasive Paraclinical Study Method for Investigation of Liver Diseases
Nina Gyorfi, Adrián Róbert Gál, András Fincsúr, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2449-2449
Open Access | Times Cited: 3
Structure, Function and Responses to Injury
James M. Crawford, Paulette Bioulac‐Sage, Prodromos Hytiroglou
Elsevier eBooks (2023), pp. 1-95
Closed Access | Times Cited: 2
Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening
Karissa E. Cottier, Devika Bhalerao, Candice Lewis, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Analysis of gene expression changes during lipid droplet formation in HepG2 human liver cancer cells
Mitsuru Chiba, Y Ohsugi, Kana Matsumoto, et al.
Medicine International (2024) Vol. 4, Iss. 1
Open Access
The effects of weight loss interventions on children and adolescents with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Mohammad Hassan Sohouli, Seyedeh Elaheh Bagheri, Somaye Fatahi, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 3
Open Access
Page 1 - Next Page

Scroll to top